1 / 6

Global Carcinoembryonic Antigen Market to grow at 6% CAGR from 2016 to 2023

Get more details @ http://bit.ly/2lBLnCC <br>Companies operating in carcinoembryonic antigen market includes Abbott Diagnostics, Roche Diagnostics, Quest Diagnostics and GenWay Biotech. Companies operating in this industry are focussing on strategies such as mergers and acquisitions to maintain leadership position.

jueekate
Download Presentation

Global Carcinoembryonic Antigen Market to grow at 6% CAGR from 2016 to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Carcinoembryonic Antigen (CEA) Market valued $2.78bn by 2023: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Carcinoembryonic Antigen Market: • Global Carcinoembryonic antigen (CEA) market size was evaluated at $1670 million for 2015 and is predicted to register CAGR of 6.6% surpassing $2800 million mark by end of forecast period. • The industry is predicted to experience high growth during forecast timeframe due to factors like growing occurrence of cancer, favourable government policies, development of new immunological methods like radioimmunoassay and growth of new biomarkers. But less sensitivity & specificity of the tests along with heavy competition from more sensitive biomarkers is predicted to hinder the industry growth. • Quest diagnostics incorporation, leading service provider of diagnostic information, had acquired Summit Health, a leading service provider of wellness & onsite prevention. The joint business is now referred as Quest diagnostics health & wellness services.

  3. Continued... • Global Carcinoembryonic antigen (CEA) market is segmented into key geographical regions including North America, Asia Pacific, Europe, Latin America and MEA. • North America led the global industry in terms of revenue for 2014 due to high occurrence of cancers in patients, favourable compensation policies, high levels of patient consciousness and presence of modern healthcare infrastructure along with comparatively greater healthcare spending in the region. • It is predicted to surpass $800 million in 2016 due to enhanced healthcare services and growing levels of consciousness to identify cancer at early phases. Further, technological breakthroughs along with launch of new particular biomarkers and antigens will fuel industry growth in the region.

  4. North America carcinoembryonic antigen market size, by application, 2014-2023 (USD Million)

  5. Browse Full Market Research Report On Carcinoembryonic Antigen Market @ http://bit.ly/2lBLnCC Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/427https://www.gminsights.com/request-sample/detail/49

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related